Abstract A fluorogenic derivatization method for the determination of chlorpropamide in human serum was developed by means of high-performance liquid chromatography (HPLC) with fluorescence detection. The Suzuki coupling reaction with a non-fluorescent reagent, phenylboronic acid (PBA), was employed to convert chlorpropamide into highly fluorescent biphenyl derivative. Chlorpropamide was extracted from human serum by liquid-liquid extraction with toluene after addition of hydrochloric acid, and subsequently reacted with PBA. Because the fluorogenic derivatization was highly selective for aryl halide, the proposed method allowed sensitive and selective detection of chlorpropamide with a detection limit (at a signal to noise ratio of 3) of 0.5 ng mL -1 . The sensitivity of our method was from 4 to 100 times better than HPLC-UV, gas chromatography, and LC-mass spectrometry.
Introduction
Chlorpropamide is one of sulphonylurea derivatives that are widely used as an oral hypoglycemic drug for the treatment of non-insulin-dependent diabetes mellitus [1] . Chlorpropamide can stimulate pancreatic beta-cell insulin production, which results in the reduction of glucose levels in blood. However, an excess dose of chlorpropamide can cause side effects including hypoglycemic symptoms and coma [2] , because it possibly stimulates excessive insulin production [3] . Therefore, monitoring therapeutic blood levels is required for the management of side effects of chlorpropamide.
Several chromatographic methods have been reported for the analysis of chlorpropamide in biological samples, such as high-performance liquid chromatography (HPLC) and micellar electrokinetic chromatography with UV detection [4] [5] [6] [7] [8] . However, because of low selectivity of UV detection, some interfering peaks appeared on the chromatogram. Other chromatographic methods with mass spectrometry (MS) were also developed [6, 9] ; however, MS equipment is not available in many laboratories.
On the other hand, we previously developed selective fluorescence derivatization techniques for aryl halides using aryl boronic acid as a reagent [10] [11] [12] [13] [14] . The derivatization techniques were based on the Suzuki coupling reaction [6] , which is a palladium-catalyzed cross-coupling reaction of aryl halides with aryl boronic acids. The techniques can selectively change drugs containing aryl halides in their structures into fluorescent derivatives. Among these techniques, the fluorogenic derivatization method using nonfluorescent phenylboronic acid (PBA) as a reagent provides a clean chromatogram because the interference derived from the reagent can be negligible [14] . The aim of this study is to develop a highly sensitive and selective HPLC method for the determination of chlorpropamide in human serum by fluorogenic derivatization using PBA (Fig. 1) . Chlorpropamide can be converted to a fluorescent biphenyl derivative after reaction with PBA because it has an aryl chloride moiety in the structure (Fig. 1) , and the derivative can be determined sensitively by fluorescence detection.
Experimental

Chemicals
PBA and p-chlorobenzaldehyde [internal standard (IS)] were purchased from Tokyo Chemical Industries (Tokyo, Japan). Palladium (II) acetate (Pd(OAc) 2 ), potassium fluoride (KF) and N,N-dimethylformamide (DMF) were from Nacalai Tesque (Kyoto, Japan). Acetonitrile, n-hexane, toluene, chloroform, diethyl ether and dichloromethane were from Kanto Chemical (Tokyo, Japan). Sodium carbonate (Na 2 CO 3 ), potassium carbonate (K 2 CO 3 ), and trisodium phosphate (Na 3 PO 4 ) were from Wako Pure Chemicals (Osaka, Japan). Water was distilled and passed through a Pure Line WL21P system (Yamato Scientific, Tokyo, Japan). All other chemicals were the highest purity and quality available.
Apparatus
The HPLC system consisted of a pump LC-6A (Shimadzu, Kyoto, Japan), a Shimadzu RF-550 fluorescence detector, a 7125 injector with a 5-lL loop (Rheodyne, Cotati, CA, USA), and a FBR-1 recorder (Tosoh, Tokyo, Japan). Chromatographic separation was performed on a Daisopak ODS-AP (250 9 4.6 mm, i.d.; Daiso, Osaka, Japan) by an isocratic elution with a mixture of acetonitrile and 1 % acetic acid (50:50, v/v %) at a flow rate of 1.0 mL min 
Result and Discussion
Optimization of Fluorogenic Derivatization Conditions
The fluorogenic derivatization conditions were optimized using a standard solution of chlorpropamide and IS. The concentration of PBA was investigated over the range 1-6 mM. As shown in Fig. 2 , since the maximum peak ). Peak height at 5 mM of PBA was defined as 100 % height for the fluorescent derivative of chlorpropamide was obtained at 5 mM; 5 mM PBA was chosen for further experiments. In the Suzuki coupling reaction, Pd(OAc) 2 and base are used as catalysts. The effects of KF, K 2 CO 3 , Na 3 PO 4 , and Na 2 CO 3 were compared to determine which base would work best in the reaction (Fig. 3) . Among the examined bases, Na 2 CO 3 was the most effective and gave maximum and constant peak heights with a concentration of more than 40 mM; 50 mM was thus chosen for further experiments.
Concentration of Pd(OAc) 2 was investigated over the range 0.1-3 mM, and the maximum peak heights were observed at concentrations over 0.5 mM; 0.5 mM Pd(OAc) 2 was selected. The temperature and time also influenced on the derivatization reaction. The reaction cannot occur efficiently when temperature is\100°C. The maximum peak heights were achieved by heating for more than 20 min at 100°C.
Optimization of Sample Preparation Conditions
For the effective extraction of chlorpropamide and IS from serum samples, commonly used liquid-liquid extraction was investigated as a sample treatment by using 200 lL serum spiked with 300 ng mL -1 chlorpropamide. n-hexane, toluene, chloroform, diethyl ether, and dichloromethane were compared as an extraction solvent, and maximum recovery was obtained with toluene. The effect of the volume of toluene was also examined. Maximal and constant recoveries were attained for 1 mL of toluene. Therefore, 1 mL of toluene was selected as the extraction solvent. Furthermore, 30 lL of hydrochloric acid was added to the extraction solvent to improve the extractability. Under the optimized conditions, the recoveries of chlorpropamide and IS were 78.0 and 40.4 %, respectively. Figure 4a , b shows typical chromatograms obtained with the extracts from drug-free human serum and serum spiked with chlorpropamide, respectively. The peak of the chlorpropamide derivative could be detected at 13 min without any interfering peaks from the serum components. ). Peak height obtained by Na 2 CO 3 was defined as 100 % Calibration Curve, Detection Limit, and Repeatability Calibration curve was prepared for human serum spiked with the standard solution of chlorpropamide. A linear relationship (r = 0.999) between the peak height ratio and the concentration of chlorpropamide was obtained in the range from 2.5 to 300 ng mL -1 . The detection limit (S/N = 3) of chlorpropamide in human serum was 0.5 ng mL -1 , which was 100, 10, and 4 times more sensitive than HPLC-UV [4, 5] , GC-MS [6] , and LC-MS [9] , respectively.
The method was validated using two levels of spiked serum (25 and 100 ng mL -1 ) for within-day (n = 5) and between-day (n = 5) repeatabilities. Relative standard deviations in the within-and between-day were \2.7 and 8.2 %, respectively.
Conclusion
A sensitive and selective HPLC method for the determination of chlorpropamide was developed by using fluorogenic derivatization based on the Suzuki coupling reaction. The proposed method was successfully applied to the determination of chlorpropamide in human serum without any interference. This method should be useful for therapeutic drug monitoring (TDM) of chlorpropamide in patients.
